Showing results (221-230 of 279) with videos related to
Sort By:
Pageof 28
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 1, 1990
Concentrations of temafloxacin in serum and bronchial mucosaD R Baldwin, L Wilkinson, J M Andrews, et al.Clinical EEG (Electroencephalography)|October 1, 1993
Contingent negative variation in Gilles de la Tourette syndromeS J Weate, S A Newell, J E Bogner, et al.The Journal of Antimicrobial Chemotherapy|June 1, 1990
Cefepime concentrations in bronchial mucosa and serum following a single 2 gram intravenous doseD Chadha, R Wise, D R Baldwin, et al.Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 1, 1996
Stimulation of the CD2 receptor pathway induces apoptosis in human T lymphotropic virus type I-infected cell linesD J Guyot, O J Trask, J M Andrews, et al.Internal Medicine Journal|August 11, 2015
Ulcerative colitis outpatient management: development and evaluation of tools to support primary care practitionersA L Bennett, S Buckton, I Lawrance, et al.Digestive Diseases and Sciences|April 3, 2022
Weight and BMI Patterns in a Biologicals-Treated IBD CohortP Kaazan, Z Tan, P Maiyani, et al.Neurogastroenterology and Motility|November 3, 2017
Performance of an algorithm-based approach to the diagnosis and management of functional gastrointestinal disorders: A pilot trialE C Linedale, A Mikocka-Walus, A D Vincent, et al.The Journal of Antimicrobial Chemotherapy|July 1, 1991
The penetration of cefpirome into the potential sites of pulmonary infectionD R Baldwin, S R Maxwell, D Honeybourne, et al.The Journal of Antimicrobial Chemotherapy|June 1, 1997
Concentrations of trovafloxacin in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum after administration of single or multiple oral doses to patients undergoing fibre-optic bronchoscopyJ M Andrews, D Honeybourne, N P Brenwald, et al.The Journal of Antimicrobial Chemotherapy|March 3, 1999
The in-vitro activity of HMR 3647, a new ketolide antimicrobial agentF J Boswell, J M Andrews, J P Ashby, et al.Pageof 28